Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 03, 2025 Filed Mar 6, 2025 01:27 UTC |
Green Kevin DennisChief Financial Officer
|
SaleCommon Stock | 60,656 | $1.58 | $95,672.71 |
DisclosureSEC source: 0000950170-25-034073 · ownership.xml · nonDerivative · entry 3 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 493,862 F5 · shares: This transaction was executed pursuant to a 10b5-1 plan. F6 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.525 to $1.67 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 01:27 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionCommon Stock | 18,550 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-034073 · ownership.xml · nonDerivative · entry 1 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 562,904 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · balance_after: Includes 3,983 and 4,278 shares purchased under Issuer's Employee Stock Purchase Plan on 08/30/24 and 02/28/25. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 22:25 UTC |
Jensen ChrystalChief Legal Officer
|
GrantRestricted Stock Unit · Derivative | 13,912 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-030172 · ownership.xml · derivative · entry 1 Jensen Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,912 Underlying: Common Stock · 13,912 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Cerus Common Stock. F3 · price: Not applicable. F2 · derivative.exercise_date: Reflects restricted stock units earned upon satisfaction of certain performance criteria in connection with a performance-based award previously granted by the Issuer. F2 · derivative.expiration_date: Reflects restricted stock units earned upon satisfaction of certain performance criteria in connection with a performance-based award previously granted by the Issuer. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 22:23 UTC |
Jayaraman Vivek KChief Operating Officer
|
GrantRestricted Stock Unit · Derivative | 23,850 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-030168 · ownership.xml · derivative · entry 1 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,850 Underlying: Common Stock · 23,850 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Cerus Common Stock. F3 · price: Not applicable. F2 · derivative.exercise_date: Reflects restricted stock units earned upon satisfaction of certain performance criteria in connection with a performance-based award previously granted by the Issuer. F2 · derivative.expiration_date: Reflects restricted stock units earned upon satisfaction of certain performance criteria in connection with a performance-based award previously granted by the Issuer. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 22:22 UTC |
Greenman William MarinerDirector · President and CEO
|
GrantRestricted Stock Unit · Derivative | 57,637 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-030165 · ownership.xml · derivative · entry 1 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,637 Underlying: Common Stock · 57,637 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Cerus Common Stock. F3 · price: Not applicable. F2 · derivative.exercise_date: Reflects restricted stock units earned upon satisfaction of certain performance criteria in connection with a performance-based award previously granted by the Issuer. F2 · derivative.expiration_date: Reflects restricted stock units earned upon satisfaction of certain performance criteria in connection with a performance-based award previously granted by the Issuer. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 22:20 UTC |
Green Kevin DennisChief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 18,550 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-030163 · ownership.xml · derivative · entry 1 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,550 Underlying: Common Stock · 18,550 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Cerus Common Stock. F3 · price: Not applicable. F2 · derivative.exercise_date: Reflects restricted stock units earned upon satisfaction of certain performance criteria in connection with a performance-based award previously granted by the Issuer. F2 · derivative.expiration_date: Reflects restricted stock units earned upon satisfaction of certain performance criteria in connection with a performance-based award previously granted by the Issuer. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 22:19 UTC |
Benjamin Richard JChief Medical Officer
|
GrantRestricted Stock Unit · Derivative | 13,912 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-030161 · ownership.xml · derivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,912 Underlying: Common Stock · 13,912 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Cerus Common Stock. F3 · price: Not applicable. F2 · derivative.exercise_date: Reflects restricted stock units earned upon satisfaction of certain performance criteria in connection with a performance-based award previously granted by the Issuer. F2 · derivative.expiration_date: Reflects restricted stock units earned upon satisfaction of certain performance criteria in connection with a performance-based award previously granted by the Issuer. Read SEC document |
| December 16, 2024 Filed Dec 17, 2024 01:34 UTC |
Jensen ChrystalChief Legal Officer
|
SaleCommon Stock | 16,667 | $1.71 | $28,500.57 |
DisclosureSEC source: 0000950170-24-136861 · ownership.xml · nonDerivative · entry 1 Jensen Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 457,578 F1 · price: This transaction was executed pursuant to a 10b5-1 plan. The sales occurred in multiple trades at prices ranging from $1.675 to $1.735. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 13, 2024 Filed Jan 2, 2025 22:46 UTC |
Gregory Dean A.Director
|
PurchaseCommon Stock | 1,725 | $1.70 | $2,932.50 |
DisclosureSEC source: 0000950170-25-000561 · ownership.xml · nonDerivative · entry 1 Gregory Dean A. · CIK 0002028395 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,725 Read SEC document |
| December 12, 2024 Filed Dec 17, 2024 01:37 UTC |
BJERKHOLT ERICDirector
|
SaleCommon Stock | 20,000 | $1.79 | $35,700.00 |
DisclosureSEC source: 0000950170-24-136863 · ownership.xml · nonDerivative · entry 1 BJERKHOLT ERIC · CIK 0001197350 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,133 F1 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.78 to $1.79 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| September 04, 2024 Filed Sep 5, 2024 21:05 UTC |
Green Kevin DennisChief Financial Officer
|
SaleCommon Stock | 54,272 | $2.15 | $116,825.91 |
DisclosureSEC source: 0000950170-24-104081 · ownership.xml · nonDerivative · entry 2 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 536,093 F2 · price: This transaction was executed pursuant to a 10b5-1 plan. The sales occurred in multiple trades at prices ranging from $2.095 to $2.20. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 21:05 UTC |
Green Kevin DennisChief Financial Officer
|
SaleCommon Stock | 28,385 | $2.18 | $61,919.04 |
DisclosureSEC source: 0000950170-24-104081 · ownership.xml · nonDerivative · entry 1 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 590,365 F1 · price: This transaction was executed pursuant to a 10b5-1 plan. The sales occurred in multiple trades at prices ranging from $2.125 to $2.25. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 20:35 UTC |
Jensen ChrystalChief Legal Officer
|
SaleCommon Stock | 16,667 | $2.07 | $34,417.36 |
DisclosureSEC source: 0000950170-24-098585 · ownership.xml · nonDerivative · entry 1 Jensen Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 474,245 F1 · price: This transaction was executed pursuant to a 10b5-1 plan. The sales occurred in multiple trades at prices ranging from $2.04 to $2.14. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 02, 2024 Filed Aug 7, 2024 20:07 UTC |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 21,605 | $2.50 | $54,012.50 |
DisclosureSEC source: 0000950170-24-092770 · ownership.xml · nonDerivative · entry 1 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 438,007 F1 · price: This transaction was executed pursuant to a 10b5-1 plan. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 20:36 UTC |
Gregory Dean A.Director
|
GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-080575 · ownership.xml · nonDerivative · entry 1 Gregory Dean A. · CIK 0002028395 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on anniversary of the transaction date, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 00:03 UTC |
Witney FrankDirector
|
GrantCommon Stock | 40,000 | $5.00 | $200,000.00 |
DisclosureSEC source: 0001209191-24-005827 · doc4.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,059 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 00:02 UTC |
Swisher Daniel N JRDirector
|
GrantCommon Stock | 40,000 | $5.00 | $200,000.00 |
DisclosureSEC source: 0001209191-24-005826 · doc4.xml · nonDerivative · entry 1 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,045 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 00:00 UTC |
Shan HuaDirector
|
GrantCommon Stock | 40,000 | $5.00 | $200,000.00 |
DisclosureSEC source: 0001209191-24-005825 · doc4.xml · nonDerivative · entry 1 Shan Hua · CIK 0001937467 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,386 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 23:59 UTC |
SCHULZE GAILDirector
|
GrantCommon Stock | 40,000 | $5.00 | $200,000.00 |
DisclosureSEC source: 0001209191-24-005824 · doc4.xml · nonDerivative · entry 1 SCHULZE GAIL · CIK 0001023259 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,420 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 23:58 UTC |
NACHTSHEIM JAMI KDirector
|
GrantCommon Stock | 40,000 | $5.00 | $200,000.00 |
DisclosureSEC source: 0001209191-24-005823 · doc4.xml · nonDerivative · entry 1 NACHTSHEIM JAMI K · CIK 0001223017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,362 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 23:57 UTC |
MOORE TIMOTHY L.Director
|
GrantCommon Stock | 40,000 | $5.00 | $200,000.00 |
DisclosureSEC source: 0001209191-24-005822 · doc4.xml · nonDerivative · entry 1 MOORE TIMOTHY L. · CIK 0001669207 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,073 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 23:54 UTC |
Lucena AnnDirector
|
GrantCommon Stock | 40,000 | $5.00 | $200,000.00 |
DisclosureSEC source: 0001209191-24-005821 · doc4.xml · nonDerivative · entry 1 Lucena Ann · CIK 0001876751 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,284 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 23:52 UTC |
BJERKHOLT ERICDirector
|
GrantCommon Stock | 40,000 | $5.00 | $200,000.00 |
DisclosureSEC source: 0001209191-24-005820 · doc4.xml · nonDerivative · entry 1 BJERKHOLT ERIC · CIK 0001197350 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,133 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| May 13, 2024 Filed May 14, 2024 22:30 UTC |
Shan HuaDirector
|
PurchaseCommon Stock | 2,500 | $1.99 | $4,974.75 |
DisclosureSEC source: 0001209191-24-005644 · doc4.xml · nonDerivative · entry 1 Shan Hua · CIK 0001937467 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,386 Read SEC document |
| May 10, 2024 Filed May 13, 2024 21:09 UTC |
NACHTSHEIM JAMI KDirector
|
PurchaseCommon Stock | 2,000 | $1.79 | $3,578.20 |
DisclosureSEC source: 0001209191-24-005628 · doc4.xml · nonDerivative · entry 1 NACHTSHEIM JAMI K · CIK 0001223017 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,362 Read SEC document |
| May 09, 2024 Filed May 9, 2024 21:15 UTC |
Swisher Daniel N JRDirector
|
PurchaseCommon Stock | 2,500 | $1.88 | $4,688.75 |
DisclosureSEC source: 0001209191-24-005600 · doc4.xml · nonDerivative · entry 1 Swisher Daniel N JR · CIK 0001323113 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,045 F1 · price: The reported price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.875 to $1.8765 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the aforementioned range set forth. Read SEC document |
| May 09, 2024 Filed May 11, 2024 00:17 UTC |
Witney FrankDirector
|
PurchaseCommon Stock | 20,000 | $1.89 | $37,800.00 |
DisclosureSEC source: 0001209191-24-005610 · doc4.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,059 Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 01:53 UTC |
Green Kevin DennisChief Financial Officer
|
SaleCommon Stock | 21,497 | $1.97 | $42,443.68 |
DisclosureSEC source: 0001209191-24-004852 · doc4.xml · nonDerivative · entry 3 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 618,750 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.935 to $2.04 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 01:47 UTC |
Jensen ChrystalChief Legal Officer
|
SaleCommon Stock | 17,824 | $1.97 | $35,191.71 |
DisclosureSEC source: 0001209191-24-004850 · doc4.xml · nonDerivative · entry 3 Jensen Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 490,912 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.935 to $2.04 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 01:33 UTC |
Jayaraman Vivek KChief Operating Officer
|
SaleCommon Stock | 26,794 | $1.97 | $52,902.07 |
DisclosureSEC source: 0001209191-24-004849 · doc4.xml · nonDerivative · entry 3 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 878,653 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.935 to $2.04 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 01:30 UTC |
Greenman William MarinerDirector · President and CEO
|
SaleCommon Stock | 63,611 | $2.02 | $128,195.25 |
DisclosureSEC source: 0001209191-24-004848 · doc4.xml · nonDerivative · entry 3 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,181,281 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.935 to $2.04 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 01:22 UTC |
CORASH LAURENCE MChief Scientific Officer
|
SaleCommon Stock | 14,360 | $1.97 | $28,352.38 |
DisclosureSEC source: 0001209191-24-004847 · doc4.xml · nonDerivative · entry 3 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,339,740 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.935 to $2.04 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 14, 2024 Filed Mar 15, 2024 01:15 UTC |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 17,738 | $1.97 | $35,021.91 |
DisclosureSEC source: 0001209191-24-004846 · doc4.xml · nonDerivative · entry 3 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 459,612 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.935 to $2.04 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 01:53 UTC |
Green Kevin DennisChief Financial Officer
|
SaleCommon Stock | 21,058 | $2.02 | $42,438.19 |
DisclosureSEC source: 0001209191-24-004852 · doc4.xml · nonDerivative · entry 2 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 640,247 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $3.03 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 01:49 UTC |
Moore CarolSVP Reg. & Quality
|
SaleCommon Stock | 10,416 | $1.97 | $20,565.35 |
DisclosureSEC source: 0001209191-24-004851 · doc4.xml · nonDerivative · entry 3 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 490,623 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F4 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.935 to $2.04 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 01:49 UTC |
Moore CarolSVP Reg. & Quality
|
SaleCommon Stock | 10,203 | $2.06 | $20,987.57 |
DisclosureSEC source: 0001209191-24-004851 · doc4.xml · nonDerivative · entry 2 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 501,039 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.025 to $2.10 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 01:47 UTC |
Jensen ChrystalChief Legal Officer
|
SaleCommon Stock | 17,460 | $2.06 | $35,915.22 |
DisclosureSEC source: 0001209191-24-004850 · doc4.xml · nonDerivative · entry 2 Jensen Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 508,736 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.025 to $2.10 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 01:33 UTC |
Jayaraman Vivek KChief Operating Officer
|
SaleCommon Stock | 26,247 | $2.06 | $53,990.08 |
DisclosureSEC source: 0001209191-24-004849 · doc4.xml · nonDerivative · entry 2 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 905,447 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.025 to $2.10 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 01:30 UTC |
Greenman William MarinerDirector · President and CEO
|
SaleCommon Stock | 62,315 | $2.06 | $128,181.96 |
DisclosureSEC source: 0001209191-24-004848 · doc4.xml · nonDerivative · entry 2 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,244,892 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.025 to $2.10 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 01:22 UTC |
CORASH LAURENCE MChief Scientific Officer
|
SaleCommon Stock | 14,067 | $2.06 | $28,935.82 |
DisclosureSEC source: 0001209191-24-004847 · doc4.xml · nonDerivative · entry 2 CORASH LAURENCE M · CIK 0001193209 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,354,100 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.025 to $2.10 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 01:15 UTC |
Benjamin Richard JChief Medical Officer
|
SaleCommon Stock | 17,377 | $2.06 | $35,744.49 |
DisclosureSEC source: 0001209191-24-004846 · doc4.xml · nonDerivative · entry 2 Benjamin Richard J · CIK 0001296322 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 477,350 F2 · shares: Represents shares sold pursuant to an instruction intended to comply with the requirements of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fee in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. F3 · price: The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.025 to $2.10 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Read SEC document |
| March 12, 2024 Filed Mar 15, 2024 01:53 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 21,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-004852 · doc4.xml · derivative · entry 4 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
| March 12, 2024 Filed Mar 15, 2024 01:53 UTC |
Green Kevin DennisChief Financial Officer
|
Exercise / conversionCommon Stock | 21,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-004852 · doc4.xml · nonDerivative · entry 1 Green Kevin Dennis · CIK 0001459351 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 661,305 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2024 Filed Mar 15, 2024 01:49 UTC |
Moore CarolSVP Reg. & Quality
|
Exercise / conversionRestricted Stock Unit · Derivative | 11,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-004851 · doc4.xml · derivative · entry 4 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
| March 12, 2024 Filed Mar 15, 2024 01:49 UTC |
Moore CarolSVP Reg. & Quality
|
Exercise / conversionCommon Stock | 11,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-004851 · doc4.xml · nonDerivative · entry 1 Moore Carol · CIK 0001574700 · SVP Reg. & Quality 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 511,242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2024 Filed Mar 15, 2024 01:47 UTC |
Jensen ChrystalChief Legal Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 16,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-004850 · doc4.xml · derivative · entry 4 Jensen Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
| March 12, 2024 Filed Mar 15, 2024 01:47 UTC |
Jensen ChrystalChief Legal Officer
|
Exercise / conversionCommon Stock | 16,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-004850 · doc4.xml · nonDerivative · entry 1 Jensen Chrystal · CIK 0001564252 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 526,196 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2024 Filed Mar 15, 2024 01:33 UTC |
Jayaraman Vivek KChief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-004849 · doc4.xml · derivative · entry 4 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
| March 12, 2024 Filed Mar 15, 2024 01:33 UTC |
Jayaraman Vivek KChief Operating Officer
|
Exercise / conversionCommon Stock | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-004849 · doc4.xml · nonDerivative · entry 1 Jayaraman Vivek K · CIK 0001605456 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 931,694 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| March 12, 2024 Filed Mar 15, 2024 01:30 UTC |
Greenman William MarinerDirector · President and CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 64,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-004848 · doc4.xml · derivative · entry 4 Greenman William Mariner · CIK 0001377258 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 64,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F6 · price: Not applicable. F5 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. F5 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning on March 12, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.